Skip to main content
. 2013 Oct 24;174(3):459–471. doi: 10.1111/cei.12200

Fig. 1.

Fig. 1

(a) Effect of dietary trans fatty acids (TFAs) on the survival (Kaplan–Meier) of 1·5% dextran sodium sulphate (DSS)-treated mice; *P < 0·05 versus the DSS group. (b) Effect of dietary TFAs on the body weight of 1·5% DSS-treated mice; *P < 0·05 versus the DSS group; #P < 0·05 versus the control. (c) Macroscopic changes in the colon on day 7 after administration of 1·5% DSS. In the control and TFA groups, there were no macroscopic changes in the tissue (upper panels). In the DSS group, stool softening and colon shortening were observed (lower left panel). The DSS with TFA group had enhanced colon shortening and haemorrhaging (lower right panel). (d) Colon length measured on day 7 after administration of 1·5% DSS; *P < 0·05 versus the control; #P < 0·05 versus the TFA group; †P < 0·05 versus the DSS group. All results are expressed as the mean (± standard error of the mean) (n = 10 mice/group).